Cardiovascular benefits of GLP-1 (liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor

Topics: 

Citation
Steven S et al. Eur Heart J 2019;40(Issue Supplement 1):ehz745.0871.